跳至主要内容
临床试验/JPRN-UMIN000042329
JPRN-UMIN000042329已完成未知

Effect of combined abnormalities in both genome sequences and immune-phenotypes in the efficacy of abatacept on patients with rheumatoid arthritis - Effect of genome and immune-phenotypes in the efficacy of abatacept

niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 111 人开始时间: 2020年11月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
111

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of allergy to any component of abatacept 2) Patients with complication by malignant tumor 3) Patients with active infection or hepatitis B and HB carrier 4) Pregnant women, lactating women or women desiring pregnancy, child delivery or breast-feeding 5) Patients judged as inappropriate for this study by Principal Investigator or Sub-investigator

研究者

发起方
niversity of Occupational and Environmental Health, Japan

相似试验